Home › Eierstokkanker › Virginia › Arlington
Eierstokkanker klinische studies in Arlington, VA
46 studies voor Eierstokkanker zoeken deelnemers op locaties in en rond Arlington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruterenGezonde vrijwilligers welkom
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Inova Fair Oaks Hospital, Fairfax · 11 mijl verwijderd
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- Inova Fairfax Hospital, Falls Church · 4 mijl verwijderd
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RekruterenFase 1/2
- Research Site, Fairfax · 11 mijl verwijderd
A Study of PHST001 in Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology - Virginia, Fairfax · 11 mijl verwijderd
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- NEXT Virginia, Fairfax · 11 mijl verwijderd
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RekruterenFase 2
- Next Virginia /ID# 279684, Fairfax · 11 mijl verwijderd
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruterenFase 1
- Site 04, Fairfax · 11 mijl verwijderd
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RekruterenFase 1
- Next Virginia /ID# 278607, Fairfax · 11 mijl verwijderd
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekruterenFase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 mijl verwijderd
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RekruterenFase 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
Study of AVZO-021 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mijl verwijderd
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RekruterenFase 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 mijl verwijderd
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruterenFase 1/2
- NEXT Oncology, Fairfax · 11 mijl verwijderd
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruterenFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruterenFase 2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
RekruterenFase 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Next Oncology Virginia, Fairfax · 11 mijl verwijderd
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
RekruterenFase 1
- NEXT Oncology, Fairfax · 11 mijl verwijderd
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RekruterenFase 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 mijl verwijderd
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruterenFase 1
- Inova Schar Cancer Institute, Falls Church · 4 mijl verwijderd
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruterenFase 1
- Normunity Investigational Site, Fairfax · 11 mijl verwijderd
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekruteren
- Inova Fairfax Hospital, Falls Church · 4 mijl verwijderd
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Inova Fair Oaks Hospital, Fairfax · 11 mijl verwijderd
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- Clinical Trial Site, Fairfax · 11 mijl verwijderd
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruterenFase 2
- 522, Fairfax · 11 mijl verwijderd
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- NEXT, Fairfax · 11 mijl verwijderd
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RekruterenFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology, Fairfax · 11 mijl verwijderd
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruterenFase 1
- Dren Investigational Site, Fairfax · 11 mijl verwijderd
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RekruterenFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Eierstokkanker studies in andere steden
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
- Pittsburgh, PA30 studies
Andere studies in Arlington
- Niet-kleincellige longkanker104 studies
- Metastatische kanker53 studies
- Colorectale kanker52 studies
- Kanker (alle vormen)48 studies
- Borstkanker47 studies
- Longkanker41 studies
- Endometriumkanker39 studies
- Aldermeesklierkanker33 studies
- Plaveiselcelcarcinoom van hoofd en hals26 studies
- Kleincellige longkanker23 studies
- Maagkanker20 studies
- Drievoudig negatieve borstkanker20 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.